Home
News Shots
Trending
Menu
×
ADVERTISEMENT
ADVERTISEMENT

Covid-19 drug

Phase II trial of Niclosamide drug against Covid begins

The trial is a multi-centric, randomised, open label clinical study to evaluate the efficacy, safety and tolerability of Niclosamide
06 June 2021, 13:58 IST
Phase II clinical trial of Niclosamide drug for treatment of Covid-19 patients begins
Phase II clinical trial of Niclosamide drug for treatment of Covid-19 patients begins

Phase II trial of Niclosamide drug against Covid begins

06 June 2021, 13:58 IST

Drug that blocks multiple Covid variants in mice found

The findings, published in the journal Science Immunology, suggest that the drug diABZI activates the body's innate immune response
31 May 2021, 08:11 IST
Drug that blocks multiple coronavirus variants in mice identified
Drug that blocks multiple coronavirus variants in mice identified

Drug that blocks multiple Covid variants in mice found

31 May 2021, 08:11 IST

Anti-Covid-19 drug: Mysuru firm makes breakthrough

17 May 2021, 08:42 IST
Anti-Covid-19 drug: Mysuru-based firm makes a breakthrough
Anti-Covid-19 drug: Mysuru-based firm makes a breakthrough

Anti-Covid-19 drug: Mysuru firm makes breakthrough

17 May 2021, 08:42 IST